Catheter Precision, Inc.
VTAK
$1.08
$0.032.86%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 130.35% | 95.00% | 82.96% | 37.61% | 9.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 130.35% | 95.00% | 82.96% | 37.61% | 9.57% |
| Cost of Revenue | 95.83% | 50.00% | 42.11% | 35.29% | 92.00% |
| Gross Profit | 134.18% | 100.00% | 87.26% | 37.81% | 4.59% |
| SG&A Expenses | -8.45% | 6.40% | 13.09% | 13.86% | 27.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.29% | 11.46% | 17.05% | 15.39% | 27.66% |
| Operating Income | 8.61% | -8.34% | -14.62% | -14.48% | -28.50% |
| Income Before Tax | -6.44% | -44.46% | -36.34% | -87.38% | -127.78% |
| Income Tax Expenses | -152.17% | -157.62% | -- | -- | -- |
| Earnings from Continuing Operations | 14.84% | -6.32% | -49.56% | -102.83% | -163.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.73% | -3.24% | -45.78% | -99.16% | -163.08% |
| EBIT | 8.61% | -8.34% | -14.62% | -14.48% | -28.50% |
| EBITDA | 9.14% | -10.20% | -17.86% | -17.59% | -45.01% |
| EPS Basic | 92.07% | 91.84% | 83.83% | 70.04% | 12.06% |
| Normalized Basic EPS | 96.48% | 94.25% | 91.31% | 77.01% | -543.41% |
| EPS Diluted | 92.07% | 91.84% | 83.83% | 70.04% | 12.06% |
| Normalized Diluted EPS | 96.48% | 94.25% | 91.31% | 77.01% | -543.41% |
| Average Basic Shares Outstanding | 376.92% | 529.57% | 1,295.80% | 1,160.87% | 786.08% |
| Average Diluted Shares Outstanding | 376.92% | 529.57% | 1,295.80% | 1,160.87% | 786.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |